Vinva Investment Management Ltd Increases Stock Position in CME Group Inc. (NASDAQ:CME)

Vinva Investment Management Ltd grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 10.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,526 shares of the financial services provider’s stock after acquiring an additional 1,509 shares during the quarter. Vinva Investment Management Ltd’s holdings in CME Group were worth $3,608,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. PineStone Asset Management Inc. lifted its stake in shares of CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the period. Assenagon Asset Management S.A. raised its stake in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after acquiring an additional 550,133 shares during the period. Ameriprise Financial Inc. raised its stake in CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after acquiring an additional 537,758 shares during the period. International Assets Investment Management LLC raised its stake in CME Group by 21,465.5% during the 3rd quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after acquiring an additional 483,618 shares during the period. Finally, Baillie Gifford & Co. bought a new stake in CME Group during the 3rd quarter worth approximately $79,692,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, Director Timothy S. Bitsberger sold 1,000 shares of the company’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the sale, the director now directly owns 10,589 shares of the company’s stock, valued at $2,403,279.44. This represents a 8.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,028 shares of company stock worth $1,811,681. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. The Goldman Sachs Group raised their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Bank of America raised their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Finally, Barclays raised their target price on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $224.47.

CME Group Trading Up 1.3 %

Shares of CME opened at $237.33 on Friday. The company’s fifty day moving average is $225.05 and its 200 day moving average is $211.73. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $238.12. The stock has a market capitalization of $85.52 billion, a PE ratio of 24.96, a P/E/G ratio of 5.29 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the business posted $2.25 earnings per share. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. Sell-side analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 1.94%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.